Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah

Stopped recruitment challenges and sites who initially expressed interest declined.

Conditions

• Lymphoma, Large B-Cell, Diffuse

Interventions

• DRUG: Cyclophosphamide
• RADIATION: TLI
• DRUG: Fludarabine

Sponsor

University Health Network, Toronto